🚀 VC round data is live in beta, check it out!
- Public Comps
- Pediatrix
Pediatrix Valuation Multiples
Discover revenue and EBITDA valuation multiples for Pediatrix and similar public comparables like Almoosa Health, National Medical Care, OdontoPrev, Dr Agarwals and more.
Pediatrix Overview
About Pediatrix
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
Founded
2007
HQ

Employees
6.6K
Website
Sectors
Financials (LTM)
EV
$2B
Pediatrix Financials
Pediatrix reported last 12-month revenue of $2B and EBITDA of $278M.
In the same LTM period, Pediatrix generated $259M in gross profit, $278M in EBITDA, and $166M in net income.
Revenue (LTM)
Pediatrix P&L
In the most recent fiscal year, Pediatrix reported revenue of $2B and EBITDA of $276M.
Pediatrix expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $2B | XXX | $2B | XXX | XXX | XXX |
| Gross Profit | $259M | XXX | $494M | XXX | XXX | XXX |
| Gross Margin | 13% | XXX | 26% | XXX | XXX | XXX |
| EBITDA | $278M | XXX | $276M | XXX | XXX | XXX |
| EBITDA Margin | 15% | XXX | 14% | XXX | XXX | XXX |
| EBIT Margin | 12% | XXX | 12% | XXX | XXX | XXX |
| Net Profit | $166M | XXX | $165M | XXX | XXX | XXX |
| Net Margin | 9% | XXX | 9% | XXX | XXX | XXX |
| Net Debt | — | — | $219M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Pediatrix Stock Performance
Pediatrix has current market cap of $2B, and enterprise value of $2B.
Market Cap Evolution
Pediatrix's stock price is $19.57.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $2B | 0.0% | XXX | XXX | XXX | $1.99 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialPediatrix Valuation Multiples
Pediatrix trades at 0.9x EV/Revenue multiple, and 6.3x EV/EBITDA.
EV / Revenue (LTM)
Pediatrix Financial Valuation Multiples
As of March 30, 2026, Pediatrix has market cap of $2B and EV of $2B.
Equity research analysts estimate Pediatrix's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Pediatrix has a P/E ratio of 9.8x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV/Revenue | 0.9x | XXX | 0.9x | XXX | XXX | XXX |
| EV/EBITDA | 6.3x | XXX | 6.4x | XXX | XXX | XXX |
| EV/EBIT | 7.4x | XXX | 7.6x | XXX | XXX | XXX |
| EV/Gross Profit | 6.8x | XXX | 3.6x | XXX | XXX | XXX |
| P/E | 9.8x | XXX | 9.8x | XXX | XXX | XXX |
| EV/FCF | 8.3x | XXX | 7.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Pediatrix Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Pediatrix Margins & Growth Rates
Pediatrix's revenue in the last 12 month grew by 1%.
Pediatrix's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.0M for the same period.
Pediatrix's rule of 40 is 16% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Pediatrix's rule of X is 17% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Pediatrix Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 1% | XXX | 1% | XXX | XXX | XXX |
| EBITDA Margin | 15% | XXX | 14% | XXX | XXX | XXX |
| EBITDA Growth | 3% | XXX | 4% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 16% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 17% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| G&A Expenses to Revenue | 12% | XXX | 13% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 14% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Pediatrix Public Comps
See public comps and valuation multiples for other Hospitals & Clinics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Almoosa Health | XXX | XXX | XXX | XXX | XXX | XXX |
| National Medical Care | XXX | XXX | XXX | XXX | XXX | XXX |
| OdontoPrev | XXX | XXX | XXX | XXX | XXX | XXX |
| Dr Agarwals | XXX | XXX | XXX | XXX | XXX | XXX |
| Draegerwerk | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Pediatrix M&A Activity
Pediatrix acquired XXX companies to date.
Last acquisition by Pediatrix was on XXXXXXXX, XXXXX. Pediatrix acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Pediatrix
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialPediatrix Investment Activity
Pediatrix invested in XXX companies to date.
Pediatrix made its latest investment on XXXXXXXX, XXXXX. Pediatrix invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Pediatrix
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Pediatrix
| When was Pediatrix founded? | Pediatrix was founded in 2007. |
| Where is Pediatrix headquartered? | Pediatrix is headquartered in United States. |
| How many employees does Pediatrix have? | As of today, Pediatrix has over 6K employees. |
| Who is the CEO of Pediatrix? | Pediatrix's CEO is Mark S. Ordan. |
| Is Pediatrix publicly listed? | Yes, Pediatrix is a public company listed on NYSE. |
| What is the stock symbol of Pediatrix? | Pediatrix trades under MD ticker. |
| When did Pediatrix go public? | Pediatrix went public in 1959. |
| Who are competitors of Pediatrix? | Pediatrix main competitors are Almoosa Health, National Medical Care, OdontoPrev, Dr Agarwals. |
| What is the current market cap of Pediatrix? | Pediatrix's current market cap is $2B. |
| What is the current revenue of Pediatrix? | Pediatrix's last 12 months revenue is $2B. |
| What is the current revenue growth of Pediatrix? | Pediatrix revenue growth (NTM/LTM) is 1%. |
| What is the current EV/Revenue multiple of Pediatrix? | Current revenue multiple of Pediatrix is 0.9x. |
| Is Pediatrix profitable? | Yes, Pediatrix is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Pediatrix? | Pediatrix's last 12 months EBITDA is $278M. |
| What is Pediatrix's EBITDA margin? | Pediatrix's last 12 months EBITDA margin is 15%. |
| What is the current EV/EBITDA multiple of Pediatrix? | Current EBITDA multiple of Pediatrix is 6.3x. |
| What is the current FCF of Pediatrix? | Pediatrix's last 12 months FCF is $211M. |
| What is Pediatrix's FCF margin? | Pediatrix's last 12 months FCF margin is 11%. |
| What is the current EV/FCF multiple of Pediatrix? | Current FCF multiple of Pediatrix is 8.3x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.